Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molidustat in Peritoneal Dialysis Subjects With Renal Anemia
NCT03418168Phase 3Completed
- Sponsor
- Bayer
- Start
- Feb 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of molidustat in anemia of chronic kidney disease, sponsored by Bayer. Started Feb 2018; status: completed.
02
Drugs
molidustat
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT03418168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03418168.